TACR1 and Nausea: CHRM3, whose-related nausea responded to ondansetron, is expressed at higher levels in the upper gastrointestinal tract compared to TACR1, whose-related nausea did not respond to ondansetron, consistent with the access of ondansetron on CHRM3 in the upper gastrointestinal tract outside the BBB.